Buy INO by Oct 26, 2026.

High short interest (\~18% of float, previously higher) + binary Oct 30 PDUFA for their lead DNA medicine. **TLDR** This is a classic high-short + defined binary catalyst setup on a micro-cap. The short thesis is “they never get a product and keep diluting.” The long/squeeze thesis is “INO-3107 clears the regulatory bar (or the path clarifies positively) and shorts have to cover into a low-float name that suddenly has a commercial story.” Oct 30 is the date. Everything between …